Table 1.

Sociodemographic and clinical characterictics according to tianeptine response in a sample of 3212 outpatients.

Subjects	Total (N = 3212)				Responder (N = 1298)				Non-responder (N = 1734)				Statistics
	N	%	Average	s.d.	N	%	Average	s.d.	N	%	Average	s.d.	Chi²	F	d.f.	p
Male	1136	37.5			504	38.8			632	36.4
Female	1896	62.5			794	61.2			1102	63.6			1.80		1	0.185
Age			49.40	14.81			48.04	14.50			50.50	15.02		20.16	1, 2980	<0.001
Adoption	24	0.8			8	0.6			16	0.9			0.840		1	0.359
Familial status	3030				1296				1734				6.94		3	0.074
School level over 12 years	1343	44.6			496	61.4			847	51.0			34.96		2	<0.001
Worker	1643	54.5			773	60.0			870	50.5			30.47		3	<0.001
First MDE	1660	54.7			792	61			868	50.1			35.99		1	<0.001
Number of previous MDE	1324	41.2	2.85	2.82	492	37.9	2.69	3.12	832	48.0	2.94	2.62		2.40	1, 1322	0.122
Age first MDE			36.20	14.21			35.49	13.35			36.62	14.68		1.91	1, 1295	0.167
Duration of previous MDE			32.93	27.01			30.43	22.5			34.47	29.34		6.42	1, 1210	0.011
Previous SA	363	12.3			118	9.3			245	14.5			18.20		1	<0.001
Number of previous SA			1.66	1.58			1.75	1.75			1.62	1.49		0.47	1, 361	0.49
Interval V1–V2 (days)			43.01	13.24			44.73	11.75			41.72	14.12		39.00	1, 3025	<0.001
V1-HAD-Anxiety			13.90	3.50			14.56	3.46			13.41	3.44		83.13	1, 3034	<0.001
V1-HAD-Depression			13.89	3.87			15.02	3.54			13.05	3.88		208.27	1, 3034	<0.001
V1-HAD-Total			27.80	6.11			29.59	5.74			26.46	6.04		208.51	1, 3034	<0.001

Significant p values are in bold.